Analysts Set Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Price

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) has earned an average recommendation of “Buy” from the seven research firms that are currently covering the firm, MarketBeat.com reports. Seven analysts have rated the stock with a buy recommendation. The average 1-year price target among brokers that have issued ratings on the stock in the last […]

Related Keywords

Canada , Sean Bohen , Cyrus Harmon , Olema Pharmaceuticals Stock Down , Virtu Financial , News Ratings For Olema Pharmaceuticals Daily , Nasdaq , Royal Bank , Citigroup Inc , Olema Pharmaceuticals Inc , Hedge Funds Weigh In On Olema Pharmaceuticals , Citigroup , Analyst Recommendations For Olema Pharmaceuticals , Olema Pharmaceuticals , Balyasny Asset Management , Securities Exchange Commission , Get Free Report , Pharmaceuticals Stock Down , Exchange Commission , Director Cyrus Harmon , Street Group , Asset Management , Get Free , Olema Pharmaceuticals Daily , Nasdaq Olma , Dolma , Medical , Ratings , Consensus ,